Retina Res Institute of Texas — Abilene, Texas

Retina Res Institute of Texas is a clinical research site located in Abilene, Texas, United States 79606.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Retina Res Institute of Texas has participated in 15 clinical trials.

Therapeutic areas: Wet Macular Degeneration, Geographic Atrophy, Diabetic Retinopathy.

Sponsors: Hoffmann-La Roche, Genentech, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Abilene

Browse all research sites in Texas · View every site in Abilene

• Retina Research Institute of Texas
• Hendrick Medical Center
• Texas Oncology West Texas
• Texas Oncology-Abilene
• Texas Cancer Center/Abilene
• Texas Cancer Center
• Hendrick Cancer Center
• Hendrick Health
• West Texas Retina Consultants P.A.
• Velocity Clinical Research Abilene
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Retina Res Institute of Texas?

Retina Res Institute of Texas has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Retina Res Institute of Texas conducted?

Retina Res Institute of Texas has 15 clinical trials on record. Their work covers Wet Macular Degeneration, Geographic Atrophy, Diabetic Retinopathy.

Is Retina Res Institute of Texas accredited by Crixeo Clinical Trials?

Retina Res Institute of Texas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Retina Res Institute of Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.